Follow
Germán Añez, MD, FIDSA
Germán Añez, MD, FIDSA
Executive Director/Distinguished Scientist, PDTL, Vaccine Clinical Research, MRL - Merck & Co., Inc.
Verified email at merck.com
Title
Cited by
Cited by
Year
Efficacy and safety of NVX-CoV2373 in adults in the United States and Mexico
LM Dunkle, KL Kotloff, CL Gay, G Áñez, JM Adelglass, ...
New England Journal of Medicine 386 (6), 531-543, 2022
3572022
Epidemiological scenario of dengue in Brazil
RCG Fares, KPR Souza, G Añez, M Rios
BioMed research international 2015, 2015
1792015
Increment of interleukin 6, tumour necrosis factor alpha, nitric oxide, C-reactive protein and apoptosis in dengue
A Levy, N Valero, LM Espina, G Añez, J Arias, J Mosquera
Transactions of the Royal Society of Tropical Medicine and Hygiene 104 (1 …, 2010
1112010
Economic impact of dengue and dengue hemorrhagic fever in the State of Zulia, Venezuela, 1997-2003
G Añez, R Balza, N Valero, Y Larreal
Revista Panamericana de Salud Pública 19 (5), 314-320, 2006
88*2006
Collaborative study to establish a World Health Organization International Reference Panel for Dengue Virus types 1 to 4 RNA for Nucleic Acid Amplification Technology (NAT …
World Health Organization, ...
World Health Organization, 2016
832016
Hepatic alterations in patients with dengue.
Y Larreal, N Valero, J Estevez, I Reyes, M Maldonado, LM Espina, J Arias, ...
Investigación clínica 46 (2), 169-178, 2005
81*2005
Circulation of different lineages of dengue virus type 2 in Central America, their evolutionary time-scale and selection pressure analysis
G Añez, ME Morales-Betoulle, M Rios
PloS one 6 (11), e27459, 2011
802011
Increased level of serum nitric oxide in patients with dengue.
N Valero, LM Espina, G Añez, E Torres, JA Mosquera
The American journal of tropical medicine and hygiene 66 (6), 762-764, 2002
792002
Dengue in the United States of America: a worsening scenario?
G Añez, M Rios
BioMed research international 2013, 2013
772013
Evolutionary dynamics of West Nile virus in the United States, 1999–2011: phylogeny, selection pressure and evolutionary time-scale analysis
G Anez, A Grinev, C Chancey, C Ball, N Akolkar, KJ Land, V Winkelman, ...
PLoS Neglected Tropical Diseases 7 (5), e2245, 2013
672013
Passage of dengue virus type 4 vaccine candidates in fetal rhesus lung cells selects heparin-sensitive variants that result in loss of infectivity and immunogenicity in rhesus …
G Añez, R Men, KH Eckels, CJ Lai
Journal of virology 83 (20), 10384-10394, 2009
612009
Immune correlates analysis of the PREVENT-19 COVID-19 vaccine efficacy clinical trial
Y Fong, Y Huang, D Benkeser, LN Carpp, G Áñez, W Woo, A McGarry, ...
Nature communications 14 (1), 331, 2023
522023
Ultrastructural studies on dengue virus type 2 infection of cultured human monocytes
JA Mosquera, JP Hernandez, N Valero, LM Espina, GJ Añez
Virology journal 2, 1-14, 2005
522005
Differential induction of cytokines by human neonatal, adult, and elderly monocyte/macrophages infected with dengue virus
N Valero, J Mosquera, A Levy, G Anez, R Marcucci, M Alvarez-Mon
Viral immunology 27 (4), 151-159, 2014
392014
Differential oxidative stress induced by dengue virus in monocytes from human neonates, adult and elderly individuals
N Valero, J Mosquera, G Anez, A Levy, R Marcucci, MA de Mon
PloS one 8 (9), e73221, 2013
372013
Phylogenetic analysis of dengue virus types 1 and 4 circulating in Puerto Rico and Key West, Florida, during 2010 epidemics
G Añez, DAR Heisey, LM Espina, SL Stramer, M Rios
The American Journal of Tropical Medicine and Hygiene 87 (3), 548, 2012
362012
Dengue virus and other arboviruses: a global view of risks
G Anez, C Chancey, A Grinev, M Rios
ISBT Science Series 7 (1), 274-282, 2012
302012
Immunogenicity and safety of a booster dose of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT) in adolescents and adults: a Phase III randomized study
G Áñez, J Hedrick, MW Simon, S Christensen, R Jeanfreau, E Yau, J Pan, ...
Human Vaccines & Immunotherapeutics 16 (6), 1292-1298, 2020
282020
Safety, immunogenicity, and efficacy of the NVX-CoV2373 COVID-19 vaccine in adolescents: a randomized clinical trial
G Áñez, LM Dunkle, CL Gay, KL Kotloff, JM Adelglass, B Essink, ...
JAMA network open 6 (4), e239135-e239135, 2023
272023
Complete genome sequences of dengue virus type 1 to 4 strains used for the development of CBER/FDA RNA reference reagents and WHO international standard candidates for nucleic …
G Añez, DA Heisey, E Volkova, M Rios
Genome announcements 4 (1), 10.1128/genomea. 01583-15, 2016
272016
The system can't perform the operation now. Try again later.
Articles 1–20